Oncology Central

ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer

A retrospective chart review presented at the ESMO World Congress on Gastrointestinal Cancer 2018 (ESMO-GI) (20–23 June, Barcelona, Spain) has demonstrated that although the treatment of metastatic pancreatic adenocarcinoma (PAC) across Europe generally follows the European Society for Medical Oncology (ESMO) guideline, there are substantial geographic variations in treatment patterns used as first-line therapies.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.